Structure | Chemical Name | CAS | MF |
|
N-(5-Methoxy-2-(pyridin-2-yl)pyrimidin-4-yl)-1H-indazol-6-amine
|
1447606-32-7
|
C17H14N6O
|
|
4-FLUORO-5-METHOXYISOINDOLINE HCL
|
1447606-44-1
|
C9H11ClFNO
|
|
tert-butyl 4-chloroquinolin-6-ylcarbaMate
|
1447606-50-9
|
C14H15ClN2O2
|
|
1-BOC-4-(CBZ-AMINO)-4-(2-METHOXY-2-OXOETHYL)PIPERIDINE
|
1447606-52-1
|
C21H30N2O6
|
|
ethyl 4-chloro-5-nitroquinoline-2-carboxylate
|
1447606-60-1
|
C12H9ClN2O4
|
|
5-(trifluoromethyl)quinolin-7-amine
|
1447606-61-2
|
C10H7F3N2
|
|
3-(3-Bromo-5-methoxyphenyl)propanenitrile
|
1447606-63-4
|
C10H10BrNO
|
|
7-Chloro-2-(4-fluorophenyl)-1H-pyrrolo[2,3-c]pyridine
|
1447606-90-7
|
C13H8ClFN2
|
|
1-(METHYL-D3)-4-NITRO-1H-PYRAZOLE
|
1447606-92-9
|
C4H2D3N3O2
|
|
ethyl 7-aminoquinoline-2-carboxylate
|
1447607-02-4
|
C12H12N2O2
|
|
tert-butyl 8-(trifluoromethyl)quinolin-3-ylcarbamate
|
1447607-03-5
|
C15H15F3N2O2
|
|
tert-Butyl methyl(3-oxobutyl)carbamate
|
1447607-14-8
|
C10H19NO3
|
|
7-Bromo-1-(4-hydroxy-2-methylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
1447607-26-2
|
C17H12BrNO4
|
|
tert-butyl 7-fluoroquinolin-4-ylcarbaMate
|
1447607-36-4
|
C14H15FN2O2
|
|
tert-butyl 7-bromoquinolin-3-ylcarbamate
|
1447607-37-5
|
C14H15BrN2O2
|
|
4-((4-Bromo-2-nitrophenyl)amino)-2-methoxyphenol
|
1447607-38-6
|
C13H11BrN2O4
|
|
N-(2-Chloro-5-methoxypyrimidin-4-yl)-1H-indazol-6-amine
|
1447607-39-7
|
C12H10ClN5O
|
|
Methyl 2-(3-aMino-1H-indazol-4-yl)benzoate
|
1447607-40-0
|
C15H13N3O2
|
|
2-(1-BOC-4-(CBZ-AMINO)-PIPERIDIN-4-YL)ACETIC ACID
|
1447607-41-1
|
C20H28N2O6
|
|
[3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-oxo-piperidin-1-yl]-acetic acid
|
1447607-51-3
|
C22H21NO5
|
|
(4-CHLORO-6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANOL
|
1447607-61-5
|
C7H5ClF3NO
|
|
tert-butyl 5-broMo-1-Methyl-1H-pyrazol-3-ylcarbaMate
|
1447607-89-7
|
C9H14BrN3O2
|
|
tert-butyl 8-bromoquinolin-2-ylcarbamate
|
1447608-01-6
|
C14H15BrN2O2
|
|
Ethyl 1,5-naphthyridine-3-carboxylate
|
1447608-02-7
|
C11H10N2O2
|
|
ethyl 4-chloro-7-nitroquinoline-2-carboxylate
|
1447608-14-1
|
C12H9ClN2O4
|
|
ethyl 5-aminoquinoline-2-carboxylate
|
1447608-15-2
|
C12H12N2O2
|
|
7-Bromo-1-(4-hydroxy-2-methylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
|
1447608-16-3
|
C17H13BrN2O3
|
|
2,2'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
|
1447669-03-5
|
C38H42B2O4
|
|
1-Bromo-2-fluoro-4-iodo-5-methoxy-benzene
|
1447671-70-6
|
C7H5BrFIO
|
|
1-Bromo-2,2-dimethyl-3,3,3-trifluoropropane
|
1447671-73-9
|
C5H8BrF3
|
|
1,3-DIBROMO-2-ETHOXY-5-FLUOROBENZENE
|
1447671-86-4
|
C8H7Br2FO
|
|
Aprepitant Impurity 15
|
1447693-83-5
|
C20H19ClF7NO2
|
|
Benzo[b]naphtho[1,2-d]thien-5-ylboronic acid
|
1447709-01-4
|
C16H11BO2S
|
|
13,14-dihydro-14,14-dimethyl-benz[c]indeno[2,1-a]carbazole
|
1447709-49-0
|
C25H19N
|
|
5-Ethylthiophene-2-boronic acid pinacol ester
|
1447710-10-2
|
C12H19BO2S
|
|
(3-fluoro-4-((4-Methylpiperazin-1-yl)sulfonyl)phenyl)boronic acid
|
1447713-71-4
|
C11H16BFN2O4S
|
|
(3-fluoro-4-(Morpholinosulfonyl)phenyl)boronic acid
|
1447713-89-4
|
C10H13BFNO5S
|
|
(2S)‐2‐amino‐2‐cycloheptylacetic acid
|
1447714-17-1
|
C9H17NO2
|
|
Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate)
|
1447715-44-7
|
C18H31NO4
|
|
Benzyl 2-Methyloxirane-2-Carboxylate
|
1447734-06-6
|
C11H12O3
|
|
Daclatasvir Impurity 7
|
1447744-93-5
|
C30H32N6O2
|
|
tert-butyl (R)-azepan-4-ylcarbamate
|
1447823-06-4
|
C11H22N2O2
|
|
Acetyl Hexapeptide-37
|
1447824-16-9
|
|
|
Palmitoyl Tripeptide-38
|
1447824-23-8
|
|
|
[5-(trifluoromethyl)thiophen-3-yl]methanol
|
1447913-56-5
|
C6H5F3OS
|
|
2-Butylbenzo[b]furan-5-carboxylicacid
|
1447931-31-8
|
C13H14O3
|
|
Tris[4-(1,1-dimethylethyl)-2-(1H-pyrazol-1-yl)pyridine]cobalt salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:3)
|
1447938-61-5
|
C38H45CoF6N10O4S2+2
|
|
(1R,3s,5S)-rel-6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid
|
1447942-40-6
|
C7H8F2O2
|
|
ethyl 6-oxospiro[2.5]octane-1-carboxylate
|
1447942-87-1
|
C11H16O3
|
|
ethyl 6,6-difluorospiro[2.5]octane-1-carboxylate
|
1447942-88-2
|
C11H16F2O2
|
|
6,6-difluorospiro[2.5]octane-1-carboxylic acid
|
1447943-53-4
|
C9H12F2O2
|
|
1-(Tert-Butoxycarbonyl)-4,4-Difluoro-2-Methylpyrrolidine-2-Carboxylic Acid
|
1447943-90-9
|
C11H17F2NO4
|
|
2,4,6-Tris[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
|
1447947-87-6
|
C39H48B3N3O6
|
|
3-bromo-6-(trifluoromethyl)quinoline
|
1447953-13-0
|
C10H5BrF3N
|
|
trans-4-AMino-4-Methylcyclohexanol hydrochloride
|
1447955-52-3
|
C7H16ClNO
|
|
ethyl 4-hydroxy-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyriMidine-6-carboxylate
|
1447956-28-6
|
C13H14N2O3S
|
|
1-(2-Thienyl)-cyclopropanemethanol
|
1447963-30-5
|
C8H10OS
|
|
2-Diphenylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl
|
1447963-71-4
|
C28H29N2P
|
|
Palladacycle Gen. 3
|
1447963-73-6
|
C41H54N3O3PPdS
|
|
Palladium[2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC][2'-(diphenylphosphino-κP)-N2,N2,N6,N6-tetramethyl[1,1'-biphenyl]-2,6-diamine](methanesulfonato-κO)-
|
1447963-74-7
|
C41H42N3O3PPdS
|
|
tBuXPhos-Pd-G3
|
1447963-75-8
|
C42H58NO3PPdS
|
|
(2-(Thiophen-3-yl)phenyl)methanamine
|
1447967-23-8
|
C11H11NS
|
|
(S)-Methyl morpholine-3-carboxylate hydrochloride
|
1447972-26-0
|
C6H12ClNO3
|
|
2,5-bis(4-(10H-phenoxazin-10-yl)phenyl)-1,3,4-oxadiazole
|
1447998-13-1
|
C38H24N4O3
|
|
6-Oxaspiro[4.5]dec-9-ylamine hydrochloride
|
1448046-14-7
|
C9H18ClNO
|
|
Ochratoxin A
|
1448049-50-0
|
C20H18ClNO6
|
|
5-Methyl-3H-imidazo[4,5-b]pyridin-6-amine
|
1448064-99-0
|
C7H8N4
|
|
(4,5,6,7-Tetrahydro-1H-benzimidazol-2-ylmethyl)amine dihydrochloride
|
1448125-97-0
|
C8H15Cl2N3
|
|
2-(Piperidin-4-yl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazole dihydrochloride
|
1448128-25-3
|
C12H21Cl2N3
|
|
5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine oxalate
|
1448137-78-7
|
C9H11N3O4
|
|
4-(trifluoromethyl)pyridazine-3-carboxylic acid
|
1448156-15-7
|
C6H3F3N2O2
|
|
Futibatinib
|
1448169-71-8
|
C22H22N6O3
|
|
N-[1,1-biphenyl]-4-yl-4-Dibenzothiophenamine
|
1448185-87-2
|
C24H17NS
|
|
VL285
|
1448188-57-5
|
C29H32N4O4S
|
|
(4-(4-methylthiazol-5-yl)phenyl)methanamine
|
1448189-30-7
|
C11H12N2S
|
|
(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride
|
1448189-80-7
|
C22H31ClN4O3S
|
|
(2S,4R)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride
|
1448189-90-9
|
C16H20ClN3O2S
|
|
2-hydroxy-4-(4-methylthiazol-5-yl)benzonitrile
|
1448190-10-0
|
C11H8N2OS
|
|
8-broMo-4,5-diMethylquinoline
|
1448230-55-4
|
C11H10BrN
|
|
Naquotinib
|
1448232-80-1
|
C30H42N8O3
|
|
Naquotinib (mesylate)
|
1448237-05-5
|
C31H46N8O6S
|
|
5-Phenyl-5,7-dihydroindolo[2,3-b]carbazole
|
1448296-00-1
|
C24H16N2
|
|
(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
|
1448297-52-6
|
C22H30N4O3S
|
|
Argatroban Impurity 38
|
1448301-07-2
|
C23H35N7O7S
|
|
1-(2-chloropyriMidin-4-yl)-3-Methyl-1H-pyrazole-4-carbaldehyde
|
1448307-66-1
|
C9H7ClN4O
|
|
2-Bromo-5-carboxyphenylboronic acid
|
1448312-00-2
|
C7H6BBrO4
|
|
Neutrophil Elastase Inhibitor
|
1448314-31-5
|
C16H11N3O
|
|
(S)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-aMine
|
1448326-32-6
|
C13H11Cl2FN2O
|
|
(S)-5-broMo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-aMine
|
1448326-33-7
|
C13H10BrCl2FN2O
|
|
Albendazole sulfone-D3
|
1448345-60-5
|
C12H12D3N3O4S
|
|
Fenbendazole-aMine hydrochloride
|
1448346-29-9
|
C13H12ClN3S
|
|
Cyclopentylalbendazole sulfone
|
1448346-31-3
|
C14H17N3O4S
|
|
Oxibendazole-aMine-D7
|
1448346-35-7
|
C10H13N3O
|
|
AMinotriclabendazole hydrochloride
|
1448346-37-9
|
C13H9Cl4N3O
|
|
Albendazole sulfoxide-D3
Ricobendazole-D3
|
1448346-38-0
|
C12H12D3N3O3S
|
|
AG-120
|
1448346-63-1
|
C28H22ClF3N6O3
|
|
Ivosidenib
|
1448347-49-6
|
C28H22ClF3N6O3
|
|
N-(2-AMinophenyl)-4-[[[(4S)-4,5-dihydro-4-phenyl-2-thiazolyl]aMino]Methyl]-benzaMide
|
1448350-50-2
|
C23H22N4OS
|
|
4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole
|
1448355-87-0
|
C16H12ClNO
|
|
1-(4,6-dichloro-1,5-naphthyridin-3-yl)ethan-1-one
|
1448361-59-8
|
C10H6Cl2N2O
|